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Background/aim: IgA deficiency is the most common human primary immunodeficiency. The prevalence of allergic disorders and
autoimmunity is thought to be increased in selective IgA deficiency (sIgAD). However, it is currently unclear if these disorders coincide
within these families. We aimed to evaluate the frequency of allergic and autoimmune disorders in children with sIgAD and their firstdegree relatives (FDRs).
Materials and methods: The study included 81 children diagnosed with sIgAD and 274 of their FDRs. The presence of allergic and
autoimmune disorders was evaluated and serum antithyroglobulin and antithyroid peroxidase levels were measured in both patients
and their first-degree relatives.
Results: The mean age of the patients was 9.9 ± 3.9 years. Among the patients with sIgAD, 45.7% of them had at least one allergic
disorder and 17.3% of them had at least one autoimmune disorder. The frequencies of asthma, allergic rhinitis, and eczema in the FDRs
of sIgAD patients were 10.9%, 9.1%, and 7.7%, respectively. Among their FDRs, 14.6% had autoimmunity, compared to an estimate of
5% in the general population.
Conclusion: Increased frequency of allergic and autoimmune disorders in patients with sIgAD and their FDRs suggests a possible
common predisposing genetic component for sIgAD and autoimmunity in these families.
Key words: allergy, autoimmunity, children, first degree relative, selective IgA deficiency

1. Introduction
Selective immunoglobulin A deficiency (sIgAD) is the
most common primary immunodeficiency, the incidence
of which varies from 1:163 to 1:18,500, depending on the
population screened and the definition of sIgAD applied
(1). Most affected individuals are asymptomatic, whereas
approximately one third of patients suffer from recurrent
mucosal infections, allergies, and autoimmune diseases (2–
4). Secretory IgA, which is present in mucosal secretions,
has a broad protective function, and in the case of sIgAD the
mucosa appears to be less protected and more vulnerable to
enteric toxins and pathogenic microorganisms (5). It has
been postulated that secretory IgA plays a protective role
against allergic disorders as well by eliminating allergens
at the mucosal level. Although an increased frequency
of allergic disorders has been reported in patients with
sIgAD, some studies have failed to demonstrate an increase
compared to the general population (6,7).
* Correspondence: merkocoglu@gmail.com
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Autoimmune disorders occur more frequently in
patients with sIgAD, with an estimated prevalence of 7%–
36% compared to 3%–5% in the general population (8–
11). The most common autoimmune conditions that have
been reported in association with sIgAD are idiopathic
thrombocytopenic purpura, hemolytic anemia, juvenile
rheumatoid arthritis, thyroiditis, celiac disease, and type 1
diabetes mellitus (T1DM) (1,12,13). Although the genetic
susceptibility behind sIgAD has not been well-defined,
pedigrees of IgA-deficient individuals show familial
clustering with no distinct Mendelian inheritance pattern
(14). Data on the prevalence of autoimmune disorders in
first-degree relatives (FDRs) of patients with sIgAD are
limited (15).
In the present study, we evaluated the prevalence
of allergic and autoimmune disorders in both IgAD
individuals and their FDRs and aimed to investigate if
sIgAD is associated with increased frequency of these
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disorders in FDRs, which may be indicative of a possible
genetic link.
2. Material and methods
2.1. Patient selection
This study was undertaken in Ankara Children’s
Hematology Oncology Education and Research Hospital
between April 1995 and July 2011 with the approval of the
local ethics committee. Individuals with sIgAD who were
followed-up at the Immunology Clinic were recruited
consecutively. Selective IgA deficiency was defined as a
serum IgA level <7 mg/dL with normal or elevated levels
of serum IgG and IgM levels in children over 4 years old.
2.2. Clinical evaluation
Clinical evaluations of participants with sIgAD and
their FDRs (sibling(s) and parents) were carried out by a
Pediatric Allergy and Immunology fellow. Demographic
and clinical characteristics were obtained for each
participant from regular medical records. History of
presenting symptoms during the diagnosis of sIgAD and
presence of recurrent infections were taken. Three or more
infection episodes in a year were accepted as recurrent
infection.
2.3. Allergic disease in patients with sIgAD
Asthma: The diagnosis of asthma was made according to
the Global Initiative for Asthma guidelines (16): Briefly,
patients older than 5 years with a history of multiple
episodes of wheezing and at least a 12% improvement in
forced expiratory volume in 1 s following bronchodilator
therapy were regarded as having asthma; patients 5 years
old or younger with a history of recurrent wheezing
episodes and a history of at least one allergic disease
(asthma, atopic dermatitis, food allergy, allergic rhinitis)
in FDRs were regarded as having asthma.
Allergic rhinitis: Presence of allergic rhinitis was only
accepted if it was diagnosed by a physician.
Food allergy: Skin prick tests and serum specific IgE
measurements were performed for the suspected food in
patients with a history of food allergy. Serum specific IgE
was measured using the Immuno-CAP system (Phadia,
Uppsala, Sweden). Food allergy diagnosis was confirmed
with an oral food challenge test.
Atopic dermatitis: This was diagnosed according to
fulfill Hanifin and Rajka’s criteria (17).
2.4. Allergic disease in FDRs
For their FDRs, life-time prevalence of physiciandiagnosed asthma, allergic rhinitis, and atopic dermatitis
was obtained from the parents of each patient. A diagnosis
of allergic disorder was only accepted if it had previously
been made by a physician with a compatible history.
2.5. Autoimmune disorders in patients with sIgAD
In patients with sIgAD, autoimmune diseases were

diagnosed by a physician specialized in that particular
subspecialty (pediatric endocrinology or pediatric
rheumatology or pediatric gastroenterology or pediatric
hematology).
2.6. Autoimmune disorders in FDRs
A detailed history of autoimmune disorders for FDRs was
obtained from the parents of each patient. The diagnosis
of autoimmunity was only accepted if it had previously
been made by a physician with a compatible history for
the corresponding form of autoimmunity.
2.7. Skin prick test
Epidermal prick tests was performed on all IgAD patients
on the volar aspect of the forearm with common airborne
allergens including house dust mites (D. pteronyssinus,
D. farinea), cat and dog danders, Alternaria alternata,
and mixed tree, mixed grass, and Parietaria officinalis
pollens (Stallergenes, SA Antony, France). Histamine (10
mg/mL) and normal saline were simultaneously used as
positive and negative controls, respectively. The test was
considered positive if the mean diameter of the wheal was
at least 3 mm greater than the negative control test after
15–20 min. Atopy was defined as the presence of at least 1
positive skin test response.
2.8. Laboratory measurements
Serum IgA, IgG, IgM, antithyroid peroxidase (anti-TPO)
antibody, and antithyroglobulin (anti-Tg) antibody levels
were measured for sIgA patients and their FDRs, while
levels of serum antigliadin IgG, antiendomysium IgG, and
antitissue transglutaminase IgG were only evaluated in
patients with IgAD.
Serum IgA, IgG, and IgM levels were measured by
nephelometry (Beckman Coulter IMMAGE 800). Serum
anti-TPO, anti-Tg, antigliadin IgG, antiendomysium IgG,
and antitissue transglutaminase IgG levels were measured
by the enzyme immunoassay (ELISA) method.
2.9. Statistical analysis
All calculations were made using SPSS version 15.0 (SPSS
Inc., Chicago, IL, USA). The results were expressed as
absolute numbers and percentage or mean ± standard
deviation (SD), where applicable. Categorical variables
were compared using the chi-square test. A P-value of <
0.05 was considered indicative of statistical significance.
3. Results
3.1. General characteristics
A total of 81 patients with sIgAD with a mean age of 9.9
± 3.9 (ranging from 4.2 to 20.4 years of age) were enrolled
in the study. Recurrent infections were found in 60 (74.1)
patients and it was also the most commonly encountered
presenting symptom of the patients with sIgAD (Table 1).
The 81 sIgAD individuals had in total 274 FDRs (112
of which were siblings) with a mean age of 26.9 ± 13.5
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Table 1. General characteristics and presenting symptoms of patients with sIgAD (n = 81).
Variable

Result
N (%)

Age (years)*

10.4 ± 3.9

Age at diagnosis (years)*

6.7 ± 2.8

Follow-up period (years)*

3.7 ± 3.0

Consanguinity

14 (17.3)

Recurrent infections

60 (74.1)

Presenting symptom
Recurrent infections

47 (58.0)

Asthma

22 (27.2)

Celiac disease

4 (4.9)

Family screening for sIgAD

3 (3.7)

Type 1 diabetes

2 (2.5)

OthersΩ

3 (3.7)

*Values provided as mean ± standard deviation, ΩOthers: acute
urticaria, pulmonary hemosiderosis, short stature

years. Among the FRDs 8 (2.9%) had sIgAD (1 mother, 2
fathers, 5 siblings). Among the 8 FDRs with sIgAD, three
had recurrent infections, two of them had asthma, and
one had thyroiditis. None of the FDRs had other forms of
hypogammaglobulinemia. The demographic and clinical
characteristics of the study population are summarized in
Table 2.
Patients with sIgAD had a mean serum IgG level of
1483 ± 383 mg/dL, with levels falling within the normal
range for age and sex in almost all patients. Only 6.2%
of sIgAD patients had elevated levels of IgG for their
age. While 12 sIgAD patients had elevated IgM levels,
16 (19.7%) patients had a serum IgE level greater than
100 mg/dL. Ten of those having IgE levels greater than
100 mg/dL had one or more allergic disorder. They had
also similar frequency of recurrent infections with those
having IgE levels lower than 100 mg/dL (75.0% and 76.9%,
respectively, P = 0.540). The results of the patients with
selective IgA deficiency and FDRs are given in Table 3.
3.2. Clinical characteristics
3.2.1. Allergic diseases
In our patient group, at least one allergic disorder was
present in 45.7% of children with sIgAD. Overall, 34.6%
of the patients had asthma, followed by allergic rhinitis
in 27.2% and atopic dermatitis in 11.1%. Following a
skin prick test, 22.2% of patients with sIgAD were found
to be sensitive to at least one allergen. One patient had
a history of physician-diagnosed food allergy. There was
no significant difference in the prevalence of allergic
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disorders between the patients with and without recurrent
infections (P = 0.220). The frequencies of asthma, allergic
rhinitis, and eczema in the FDRs of sIgAD patients
were 10.9%, 9.1%, and 7.7%, respectively (Table 2). The
prevalence of asthma and allergic rhinitis was higher in
patients with sIgAD compared to their FDRs (P < 0.001
and P = 0.019, respectively), while there was no difference
in terms of the frequency of atopic dermatitis (P = 0.939).
Overall, 32.1% of the children with IgAD had at least 1
FDR with an allergic disorder, while among the children
with a confirmed allergic disorder, 43.2% also had at least
1 similarly affected FDR.
3.2.2. Autoimmune disorders
At least one physician-diagnosed autoimmune disorder
was present in 14 (17.3%) of the patients with sIgAD,
the most common condition being celiac disease (9.9%),
followed by type-1 diabetes mellitus (DM) (3.7%) and
thyroiditis (2.5%). Two patients had both celiac disease and
thyroiditis and 1 patient had type-1 DM and celiac disease,
while 1 patient had FMF and ankylosing spondylitis (table
3). There was no significant difference in the prevalence
of autoimmune disorders between the patients with and
without recurrent infections (P = 0.358).
Four patients with sIgAD had detectable levels of TPO,
whereas three of them were positive for anti-Tg antibodies.
Two of the patients with thyroid autoantibody positivity
had clinically hypothyroidism (Table 3). Eight patients
were eventually diagnosed with celiac disease for having
positive titers of antigliadin IgG, antiendomysium IgG,
and antitissue transglutaminase IgG antibodies.
Among the FDRs, 24 were positive for anti-TPO and
20 had detectable levels of anti-Tg antibody. In subjects
with positive thyroid antibodies, 15 of them had a history
of clinical thyroiditis (hypothyroidism) and patients
without a compatible clinical history were not considered
to have thyroiditis. The individuals with positive thyroid
autoantibodies had a mean age of 33.9 ± 9.8 years and
75.8% of them were female. Overall, 14.6% of the FDRs
enrolled had a history of at least one physician-diagnosed
autoimmune condition, the most frequent being
thyroiditis (9.1%) and rheumatoid arthritis (2.6%). The
difference between patients with IgAD and their FDRs
with regards to the frequency of autoimmune disorders
was statistically insignificant (P = 0.554). Overall, 38.3%
of the children with IgAD had at least one FDR with an
autoimmune disorder, while among the children with a
confirmed autoimmune disorder, 42.9% also had at least
one similarly affected FDR.
4. Discussion
In this study, we demonstrated a higher frequency of
allergic and autoimmune disorders in patients with IgAD
compared to the general population, while at the same
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Table 2. Demographic characteristics and frequencies of allergic and autoimmune disorders in
sIgAD patients and their FDRs.
sIgAD
(n = 81)

FDRs
(n = 274)

P

Age (mean ± SD, in years)

10.4 ± 3.9

26.9 ± 13.5

<0.001

Female n (%)

133 (48.6)

141 (51.4)

0.037

Asthma

28 (34.6%)

30 (10.9)

<0.001

Allergic rhinitis

22 (27.2%)

25 (9.1)

0.019

Atopic dermatitis

9 (11.1%)

21 (7.7)

0.939

Food allergy

1 (1.2%)

-

-

>1 allergic disease

17 (21.0)

14 (5.1)

<0.001

14 (17.3)

40 (14.6)

0.554

Celiac disease

8 (9.9)

1 (0.3)

T1DM

3 (3.7)

2 (0.7)

Thyroiditis

2 (2.5)

25 (9.1)

FMF

1 (1.2)

2 (0.7)

Vitiligo

1 (1.2)

2 (0.7)

Chronic ITP

1 (1.2)

-

Rheumatoid arthritis

-

7 (2.6)

Pulmonary hemosiderosis

1 (1.2)

-

>1 autoimmune disease

4 (4.9)

-

Allergic disorders n (%)

Autoimmune disease n (%)
Total

sIgAD: selective immunoglobulin A deficiency; FDRs: first-degree relatives; T1DM: type 1
diabetes mellitus; FMF: familial Mediterranean fever; mean ± SD: mean ± standard deviation

time showing an increased risk of autoimmunity in their
FDRs, again compared to the general population. In fact,
in a significant proportion of our patients with IgAD
the presenting symptoms were related to an underlying
allergic and/or autoimmune disorder.
Although it is widely accepted that allergic diseases
occur more commonly in patients with sIgAD, some
studies have reported disease frequencies comparable
to those of the general population. In an earlier study,
Buckley et al. reported the frequency of atopy in children
and adults with sIgAD as 58% (18). Edwards et al. later
reported a frequency of allergy/asthma of 13% in patients
with sIgAD, where they also found a higher prevalence
of allergy in younger individuals (10). In a more recent
study by Aytekin et al., allergic manifestations including
asthma, atopic dermatitis, allergic rhinitis/conjunctivitis,
urticaria, drug allergy, and food allergy were noted in
43.2% of children (age range 4–18 years) with sIgAD (4).
In our study, 34.6% of the patients with sIgAD had asthma,
27.2% had allergic rhinitis, and 11.1% had eczema, while a
further 22.2% were sensitized to at least 1 allergen on a skin

prick test. In a recent study from Turkey, the prevalence of
physician-diagnosed asthma, allergic rhinitis, and eczema
in school-age children was reported as 10.7%, 16.9%, and
2.6%, respectively (19). When our findings are compared
to these results, it would seem that asthma and eczema
occur more commonly in children with sIgAD.
It is widely thought that the absence of the protective
effect of secretory IgA on the mucosal surface, which in
turn facilitates the passage of aeroallergens and food
allergens in the respiratory and gastrointestinal tracts, is
mainly responsible for the increased incidence of allergic
diseases associated with sIgAD by increasing the likelihood
of sensitization against such antigens (20,21). Although
only 1 patient in our study had a physician-diagnosed food
allergy, results of a recent study showing an increase in the
frequency of food allergies in 4-year-old children support
this hypothesis (6). The absence of secretory IgA and its
protective effects allows viruses to overcome mucosal
defenses, thus leading to upper and lower respiratory tract
infections (LRTIs) and it has been shown that viral LRTIs,
especially rhinovirus, are related with increased incidence
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Table 3. Laboratory findings of patients with sIgAD and their FDRs.

IgA (<7 mg/dL)

sIgAD (N = 81)
n (%)

FDR (N = 274)
N (%)

81 (100)

8 (2.9)

IgG (mg/dL)*

1483.5 ± 383.4

1219.3 ± 299.1

IgM (mg/dL)*

113.5 ± 41.5

134.3 ± 76.9

IgE (mg/dL)*

92.0 ± 175.6

59.6 ± 89.9

Anti-TPO, positive

4 (4.9)

24 (8.7)

Anti-TG, positive

3 (3.7)

20 (7.3)

Skin prick test, positive

18 (22.2)

ND

Antigliadin IgG,

8 (9.9)

ND

Antiendomysium IgG

8 (9.9)

ND

Antitissue transglutaminase IgG

8 (9.9)

ND

IgA: immunoglobulin A; IgE: immunoglobulin E IgG: immunoglobulin G; IgM:
immunoglobulin M; Anti-Tg: anti-thyroglobulin antibody; Anti-TPO: anti-thyroid
peroxidase antibody; ND: not done; sIgAD: selective immunoglobulin A deficiency;
FDRs: first-degree relatives; *Values provided as mean ± standard deviation

of asthma (22). These mechanisms related to secretory IgA
are more likely to play a role in the development of allergic
disorders.
A genetic susceptibility has yet to be identified in
association with sIgAD. Although the pedigrees of
individuals with sIgAD do show familial clustering, there
is no evidence to support Mendelian inheritance (14).
In a recent prevalence study from Turkey, Baştürk et al.
reported the frequency of sIgAD among school children
as 1:188, whereas in our study we observed a frequency
of 1:34 among the FDRs of individuals with sIgAD (23).
Our findings are suggestive of the presence of a genetic
component to disease susceptibility.
Autoimmune disorders are one of the most important
clinical manifestations in individuals with sIgAD (24–26).
The prevalence of autoimmunity in IgAD individuals
has been shown to be highly variable, ranging from 7%
to 36% in symptomatic IgAD individuals (27), whereas
the prevalence of autoimmune disorders in the general
population is estimated to be between 3% and 5%
(8,9). Recently, Jacob et al. reported the frequency of
autoimmunity as 19% in their sIgAD patients, which is
similar to our results (28). In our study, the frequency
of autoimmunity was 17.3% in children with sIgAD
compared to a frequency of 14.6% in their FDRs, both of
which are higher than in the general population. Although
data regarding the prevalence of autoimmune diseases
in Turkey is lacking, a recent study reported an overall
prevalence of 1% for rheumatoid arthritis, whereas the
frequency for the same disorder among the FDRs in our
study was 3.8% (29). In our study population 1.2% of
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sIgAD patients and 0.7% of their FDRs had FMF, which
were much higher than the prevalence of FMF (0.093%) in
the general Turkish population (30).
Celiac disease was present in 9.9% of our sIgAD
patients. Several studies in the literature reported a higher
prevalence of celiac disease in patients with sIgAD, as
well as a higher frequency of sIgAD among patients with
confirmed celiac disease (13,31). A recent study from
Turkey reported the prevalence of celiac disease as 0.47%
in healthy school children, which is much lower than the
prevalence in our sIgAD patients (32). The exact nature
of the relationship between these two conditions remains
elusive. However, human leukocyte antigen alleles and
haplotypes such as HLAB8, DR3, DR7, and DQ2 have
been shown to occur more frequently in both conditions,
suggesting a possible link with human leukocyte antigens
(33,34). On the other hand, the absence of mucosal IgA
in patients with sIgAD disrupts mucosal clearance of
food antigens, and the passage of some molecules into
subepidermal and submucosal tissue may facilitate
the production of antibodies against these antigens in
individuals with a genetic susceptibility for developing
celiac disease.
Several hypotheses have been put forth to help explain
the relationship between sIgAD and autoimmunity (35).
The absence of secretory IgA in the mucosal surfaces
compromises mucosal integrity, thus allowing for
unhindered passage of environmental antigens into the
systemic circulation, and these dietary proteins may
result in cross-reactions with self-antigens. Antibodies
against cow’s milk, among other autoantibodies, have
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been detected more frequently in patients with selective
IgA. Another hypothesis could be that the decrease in
antigen clearance may lead to tissue inflammation via the
formation of immune complexes.
Besides the above-mentioned immune mechanisms,
it has been postulated that homozygosity for certain
haplotypes of the major histocompatibility complex
genes could be a risk factor for the development of some
autoimmune diseases in patients with sIgAD, with some
studies showing a higher frequency of certain MHC
haplotypes in individuals with sIgAD and their families
(36,37). Recently, the possibility of a link between some
non-HLA candidate genes and sIgAD has been reported
(38).
It has been well documented that sIgAD is associated
with an increased frequency of autoimmune disorders.
Moreover, a recent study has also demonstrated the
presence of familial clustering for autoimmune disorders
(8). The fact that both sIgAD and autoimmune diseases
show familial clustering and that sIgAD is associated
with an increased frequency of autoimmunity raises a
question regarding whether FDRs of patients of sIgAD
are also at risk. In a recent study by Jorgensen et al., a
higher frequency of autoimmune diseases was reported in
FDRs of individuals with sIgAD compared to the general
population (15). Our study also produced similar results.
Furthermore, we observed that up to 38.3% of children
with sIgAD had at least one relative with an autoimmune

disorder, with the frequency rising to 42.9% among FDRs
of children who had an autoimmune disease themselves.
Besides these, antibodies against thyroglobulin and TPO
were positive in 3.7% and 4.9% of children with sIgAD,
respectively, compared to respective positivity rates of
8.7% and 7.2% in their FDRs. Besides the high frequency
of thyroid autoantibodies, 9.1% of FDRs had physiciandiagnosed thyroiditis. These findings suggest that selective
IgA deficiency is associated with increased autoimmune
disorders in the FDRs of these patients.
The main limitation of this study is the lack of a control
group. Due to this, we compared our results with those of
population-based studies, and the frequencies of allergic
and autoimmune diseases were higher in patients with
sIgAD and the frequency of autoimmune disorders was
higher in their FDR (8,9,29,30,32).
With this study, we demonstrated an increased
frequency of autoimmune diseases in the FDRs of patients
with sIgAD compared to the general population, a finding
that suggests a possible common predisposing genetic
component for sIgAD and autoimmunity in these families.
Furthermore, besides a history of recurrent infections,
a significant proportion of children with sIgAD may
present with symptoms related to an underlying allergic
or autoimmune condition. A diagnosis of sIgA deficiency
deserves consideration in the differential diagnosis in
patients presenting with an autoimmune or allergic
disorder.
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